巨子 ICON - 財經股票資訊及專家分析
搜尋 股票

Oncocyte Corp

OCX
最少15分鐘延遲,股票資訊由第三方資訊供應商提供
・Oncocyte Corp - 延遲價格・最後更新於 19/01 8:59
最高位
2.110
最低位
1.655
開市價
--
前收市價
2.200
成交量(千)
63.60
成交額(百萬)
0.95
買入
--
賣出
2.000
每手股數
--
市值(百萬)
154.03
市盈率
--
息率
--
差價
--
52週高低
6.570 - 1.650
所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

企業資料

公司名稱
Oncocyte Corp
證券代碼
OCX.US
所屬板塊
Biotechnology
公司業務
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. It develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, the company also developing screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through United States and it earns revenue from the sale of diagnostic tests.
發行量
89868418
董事局成員
    公司總部
    15 Cushing
    公司網址
    https://www.oncocyte.com
    公司電郵
    APrior@evcgroup.com
    公司電話
    +1 949 409-7600
    暫無內容

    關於

    Oncocyte Corp(OCX.US)所屬的行業板塊為Biotechnology。
    OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. It develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, the company also developing screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through United States and it earns revenue from the sale of diagnostic tests.
    詳細公司背景可參考: https://www.oncocyte.com